Diagnosis of cancer of the cervix by targeting VPAC receptors on exfoliated cervical cells

Introduction: Cervical cancer is a major cause of cancer morbidity and mortality in women. Screening for cervical cancer reduces mortality through early detection and treatment. The success of the screening for cervical cancer has been largely attributed to the use of Pap smear (Papanicolaou). The o...

Full description

Bibliographic Details
Main Authors: Rajendra B. Nerli, Kumar Vinchurkar, Mahesh Kalloli, Shadab Rangrez, Shridhar C. Ghagane, Madhukar L. Thakur
Format: Article
Language:English
Published: Sociedade Brasileira de Oncologia Clínica, Sociedade Brasileira de Cirurgia Clínica and Sociedade Brasileira de Radioterapia 2023-04-01
Series:Brazilian Journal of Oncology
Subjects:
Online Access:https://www.brazilianjournalofoncology.com.br/details/240/en-US/diagnosis-of-cancer-of-the-cervix-by-targeting-vpac-receptors-on-exfoliated-cervical-cells
_version_ 1797346352852631552
author Rajendra B. Nerli
Kumar Vinchurkar
Mahesh Kalloli
Shadab Rangrez
Shridhar C. Ghagane
Madhukar L. Thakur
author_facet Rajendra B. Nerli
Kumar Vinchurkar
Mahesh Kalloli
Shadab Rangrez
Shridhar C. Ghagane
Madhukar L. Thakur
author_sort Rajendra B. Nerli
collection DOAJ
description Introduction: Cervical cancer is a major cause of cancer morbidity and mortality in women. Screening for cervical cancer reduces mortality through early detection and treatment. The success of the screening for cervical cancer has been largely attributed to the use of Pap smear (Papanicolaou). The objective of this study was to assess the feasibility of detecting cervical cancer by targeting genomic VPAC receptors and compare the results with those of Pap-test. Material and Methods: Women ≥40 years of age underwent routine screening for cervical cancer. The cellular material obtained from the cervix was gently smeared on a clean glass slide. The slides were then stained according to Papanicolaou’s technique. Similarly, another set of prepared smears were used for VPAC receptor detection. Histopathological examination of the cervical biopsy was done and the results of all three tests were compared. Results: A total of 114 women attending the Gynaecology outpatient department of our hospital were included in the study. Histopathological examination (HPR) of the cervical biopsy revealed that 25 patients had cervical cancer and the remaining 89 were negative for cervical cancer. The Pap smear gave positivity for malignant cells in 20 (80%) of cases reconfirmed on HPR. The false positive rate and false negative rates were 4.5% and 20%, respectively. The VPAC receptors were positive in 23 (92%) of the 25 cases with cancer of the cervix. The false positive and false negative rates were 2.2% and 8%, respectively. Conclusions: Diagnosis of cancer of the cervix can be reliably made by targeting the genomic VPAC receptors. The test is simple to perform, reliable, reproducible and with minimal false positivity having a higher diagnostic accuracy.
first_indexed 2024-03-08T11:32:15Z
format Article
id doaj.art-43985508bdc34952a8975403a5258d8b
institution Directory Open Access Journal
issn 2526-8732
language English
last_indexed 2024-03-08T11:32:15Z
publishDate 2023-04-01
publisher Sociedade Brasileira de Oncologia Clínica, Sociedade Brasileira de Cirurgia Clínica and Sociedade Brasileira de Radioterapia
record_format Article
series Brazilian Journal of Oncology
spelling doaj.art-43985508bdc34952a8975403a5258d8b2024-01-25T17:27:36ZengSociedade Brasileira de Oncologia Clínica, Sociedade Brasileira de Cirurgia Clínica and Sociedade Brasileira de RadioterapiaBrazilian Journal of Oncology2526-87322023-04-011910.5935/2526-8732.20230378Diagnosis of cancer of the cervix by targeting VPAC receptors on exfoliated cervical cellsRajendra B. Nerli0Kumar Vinchurkar1Mahesh Kalloli2Shadab Rangrez3Shridhar C. Ghagane4Madhukar L. Thakur5JN Medical College, KLE Academy of Higher Education & Research (Deemed-to-be-University), Urology & Urologic-Oncology - Belagavi - Karnataka - India.JN Medical College, KLE Academy of Higher Education & Research (Deemed-to-be-University), Department of Surgical-Oncology - Belagavi - Karnataka - India.JN Medical College, KLE Academy of Higher Education & Research (Deemed-to-be-University), Department of Surgical-Oncology - Belagavi - Karnataka - India.JN Medical College, KLE Academy of Higher Education & Research (Deemed-to-be-University), Urology & Urologic-Oncology - Belagavi - Karnataka - India.KAHERs Dr. Prabhakar Kore Basic Science Research Center, Department of Biotechnology - Belagavi - Karnataka - India.Departments of Urology, Radiology, Thomas Jefferson University - Philadelphia, - PA, USA - United States.Introduction: Cervical cancer is a major cause of cancer morbidity and mortality in women. Screening for cervical cancer reduces mortality through early detection and treatment. The success of the screening for cervical cancer has been largely attributed to the use of Pap smear (Papanicolaou). The objective of this study was to assess the feasibility of detecting cervical cancer by targeting genomic VPAC receptors and compare the results with those of Pap-test. Material and Methods: Women ≥40 years of age underwent routine screening for cervical cancer. The cellular material obtained from the cervix was gently smeared on a clean glass slide. The slides were then stained according to Papanicolaou’s technique. Similarly, another set of prepared smears were used for VPAC receptor detection. Histopathological examination of the cervical biopsy was done and the results of all three tests were compared. Results: A total of 114 women attending the Gynaecology outpatient department of our hospital were included in the study. Histopathological examination (HPR) of the cervical biopsy revealed that 25 patients had cervical cancer and the remaining 89 were negative for cervical cancer. The Pap smear gave positivity for malignant cells in 20 (80%) of cases reconfirmed on HPR. The false positive rate and false negative rates were 4.5% and 20%, respectively. The VPAC receptors were positive in 23 (92%) of the 25 cases with cancer of the cervix. The false positive and false negative rates were 2.2% and 8%, respectively. Conclusions: Diagnosis of cancer of the cervix can be reliably made by targeting the genomic VPAC receptors. The test is simple to perform, reliable, reproducible and with minimal false positivity having a higher diagnostic accuracy.https://www.brazilianjournalofoncology.com.br/details/240/en-US/diagnosis-of-cancer-of-the-cervix-by-targeting-vpac-receptors-on-exfoliated-cervical-cellsdiagnosiscervix utericancer symptoms
spellingShingle Rajendra B. Nerli
Kumar Vinchurkar
Mahesh Kalloli
Shadab Rangrez
Shridhar C. Ghagane
Madhukar L. Thakur
Diagnosis of cancer of the cervix by targeting VPAC receptors on exfoliated cervical cells
Brazilian Journal of Oncology
diagnosis
cervix uteri
cancer symptoms
title Diagnosis of cancer of the cervix by targeting VPAC receptors on exfoliated cervical cells
title_full Diagnosis of cancer of the cervix by targeting VPAC receptors on exfoliated cervical cells
title_fullStr Diagnosis of cancer of the cervix by targeting VPAC receptors on exfoliated cervical cells
title_full_unstemmed Diagnosis of cancer of the cervix by targeting VPAC receptors on exfoliated cervical cells
title_short Diagnosis of cancer of the cervix by targeting VPAC receptors on exfoliated cervical cells
title_sort diagnosis of cancer of the cervix by targeting vpac receptors on exfoliated cervical cells
topic diagnosis
cervix uteri
cancer symptoms
url https://www.brazilianjournalofoncology.com.br/details/240/en-US/diagnosis-of-cancer-of-the-cervix-by-targeting-vpac-receptors-on-exfoliated-cervical-cells
work_keys_str_mv AT rajendrabnerli diagnosisofcancerofthecervixbytargetingvpacreceptorsonexfoliatedcervicalcells
AT kumarvinchurkar diagnosisofcancerofthecervixbytargetingvpacreceptorsonexfoliatedcervicalcells
AT maheshkalloli diagnosisofcancerofthecervixbytargetingvpacreceptorsonexfoliatedcervicalcells
AT shadabrangrez diagnosisofcancerofthecervixbytargetingvpacreceptorsonexfoliatedcervicalcells
AT shridharcghagane diagnosisofcancerofthecervixbytargetingvpacreceptorsonexfoliatedcervicalcells
AT madhukarlthakur diagnosisofcancerofthecervixbytargetingvpacreceptorsonexfoliatedcervicalcells